Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us

Lundbeck Sees $179 Million in Sales for New Drug, Berlingske Say

Dec. 6 (Bloomberg) -- H. Lundbeck A/S expects its experimental epilepsy treatment clobazam, if approved, will generate annual sales of more than billion kroner ($179 million), Berlingske Tidende reported, citing spokesman Mads Kronborg.

Lundbeck released trial results over the weekend which showed the two highest doses of the medicine, when added on to existing therapy, cut the number of seizures that patients experienced by a statistically significant amount.

Click here for web link

To contact the editor responsible for this story: Frances Schwartzkopff at fschwartzko1@bloomberg.net

Please upgrade your Browser

Your browser is out-of-date. Please download one of these excellent browsers:

Chrome, Firefox, Safari, Opera or Internet Explorer.